Literature DB >> 34330716

Cytochrome b 5 Binds Tightly to Several Human Cytochrome P450 Enzymes.

Donghak Kim1, Vitchan Kim1, Yasuhiro Tateishi1, F Peter Guengerich2.   

Abstract

Numerous studies have been reported in the past 50-plus years regarding the stimulatory role of cytochrome b 5 (b 5) in some, but not all, microsomal cytochrome P450 (P450) reactions with drugs and steroids. A missing element in most of these studies has been a sensitive and accurate measure of binding affinities of b 5 with P450s. In the course of work with P450 17A1, we developed a fluorescent derivative of a human b 5 site-directed mutant, Alexa 488-T70C-b 5, that could be used in binding assays at sub-μM concentrations. Alexa 488-T70C-b 5 bound to human P450s 1A2, 2B6, 2C8, 2C9, 2E1, 2S1, 4A11, 3A4, and 17A1, with estimated K d values ranging from 2.5 to 61 nM. Only weak binding was detected with P450 2D6, and no fluorescence attenuation was observed with P450 2A6. All of the P450s that bound b 5 have some reported activity stimulation except for P450 2S1. The affinity of P450 3A4 for b 5 was decreased somewhat by the presence of a substrate or inhibitor. The fluorescence of a P450 3A4•Alexa 488-T70C-b 5 complex was partially restored by titration with NADPH-P450 reductase (POR) (K d,apparent 89 nM), suggesting the existence of a ternary P450 3A4-b 5-POR complex, as observed previously with P450 17A1. Gel filtration evidence was also obtained for this ternary complex with P450 3A4. Overall, the results indicated that the affinity of b 5 for many P450s is very high, and that ternary P450-b 5-POR complexes are relevant in P450 3A4 reactions as opposed to a shuttle mechanism. SIGNIFICANCE STATEMENT: High-affinity binding of cytochrome b 5 (b 5) (K d < 100 nM) was observed with many drug-metabolizing cytochrome P450 (P450) enzymes. There is some correlation of binding with reported stimulation, with several exceptions. Evidence is provided for a ternary P450 3A4-b 5-NADPH-P450 reductase complex.
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34330716      PMCID: PMC8626640          DOI: 10.1124/dmd.121.000475

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.579


  66 in total

1.  Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver.

Authors:  I H Hanna; J R Reed; F P Guengerich; P F Hollenberg
Journal:  Arch Biochem Biophys       Date:  2000-04-01       Impact factor: 4.013

2.  A model of the membrane-bound cytochrome b5-cytochrome P450 complex from NMR and mutagenesis data.

Authors:  Shivani Ahuja; Nicole Jahr; Sang-Choul Im; Subramanian Vivekanandan; Nataliya Popovych; Stéphanie V Le Clair; Rui Huang; Ronald Soong; Jiadi Xu; Kazutoshi Yamamoto; Ravi P Nanga; Angela Bridges; Lucy Waskell; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2013-05-24       Impact factor: 5.157

3.  Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes.

Authors:  Aaron G Bart; Emily E Scott
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

4.  Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.

Authors:  P Sandhu; T Baba; F P Guengerich
Journal:  Arch Biochem Biophys       Date:  1993-11-01       Impact factor: 4.013

5.  Purification and characterization of cytochrome P-450 with high affinity for cytochrome b5.

Authors:  N Miki; T Sugiyama; T Yamano
Journal:  J Biochem       Date:  1980-08       Impact factor: 3.387

6.  Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. I. Effects of activation and inhibition of the fatty acyl coenzyme A desaturation system.

Authors:  M A Correia; G J Mannering
Journal:  Mol Pharmacol       Date:  1973-07       Impact factor: 4.436

7.  Cytochrome b5 as electron donor for oxy-cytochrome P-450.

Authors:  M Noshiro; V Ullrich; T Omura
Journal:  Eur J Biochem       Date:  1981-06-01

8.  Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-05-29       Impact factor: 3.739

9.  Determination of cytochrome b5 association reactions. Characterization of metmyoglobin and cytochrome P-450cam binding to genetically engineered cytochromeb5.

Authors:  P S Stayton; M T Fisher; S G Sligar
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

10.  Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1.

Authors:  Zhong-Liu Wu; Christal D Sohl; Tsutomu Shimada; F Peter Guengerich
Journal:  Mol Pharmacol       Date:  2006-03-21       Impact factor: 4.436

View more
  1 in total

1.  Binding of cytochrome P450 27C1, a retinoid desaturase, to its accessory protein adrenodoxin.

Authors:  Sarah M Glass; Stephany N Webb; F Peter Guengerich
Journal:  Arch Biochem Biophys       Date:  2021-10-31       Impact factor: 4.013

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.